OXYGENTA PHARMACEUTICAL
|
The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 2.25.
Share Price | ₹68.5 | Sep 29,2025 |
Market Cap | ₹253.6 Cr | |
Sales-TTM | ₹112.6 Cr | TTM-Standalone Results |
Price/Sales | 2.25x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹253.6 Cr] as on Sep 29,2025
(/) Sales [ ₹112.6 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 2.25x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '2.25 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL
PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.94x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 2.45x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
OXYGENTA PHARMACEUTICAL | 112.6 | 2.25 | 253.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.10 | 381,686.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 15.67 | 151,241.0 |
CIPLA LTD | 27,811.2 | 4.32 | 120,240.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.25 | 121,339.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.08 | 103,091.0 |
MANKIND PHARMA LTD | 12,956.2 | 7.84 | 101,574.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.23 | 99,843.6 |
LUPIN LTD | 23,375.9 | 3.77 | 88,206.8 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.97 | 63,202.8 |
ABBOTT INDIA LTD | 6,589.9 | 9.56 | 62,994.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.97x |
Max industry PS | 15.67x |
Median industry PS | 4.32x |
Average industry PS | 6.37x |
You may also like the below Video Courses